The Central Drugs Standard Control Organisation has found Alkem Labs’ anti-diabetic drug Glimekem to be of substandard quality. This is the third time in the past one year that the......
The Israel-based multinational Taro Pharmaceutical Industries has struck its first outsourcing deal with Indian major Alkem Laboratories for formulations development and supply contract for its US......
Six pharma majors were sent seven alerts last financial year At least six major pharmaceutical companies, including Cipla, Ipca Labs, Alkem Labs, Morepen Labs, Abbott and Sanofi were found......
Probiotics, the new generation biotech drugs and dietary supplements developed from yeast or lactic acid bacteria, is emerging as a major opportunity in the domestic and international markets for......
The tailwind of low price erosion in the US generics market, seen by domestic pharmaceutical companies in calendar year 2023 (CY23), may be reversing slowly, caution analysts. Illustration: Uttam......